Acadia Pharmaceuticals Inc.
$4.96B- Market cap
- $4.83B
- Debt
- +$306.51M
- Cash
- −$177.70M
Capital structure 94% equity / 6% debt · EV / Revenue 4.63x · EV / EBITDA 32.92x
Quick read
Fair value engine
Each company valued on the other's multiple, then compared with the market price.
ACAD · current priceP/E 12.19x
$28.04Latest market snapshot
Implied fair value · at DDOG's multiple
$1,580.105,535.2% above market
2.30 ACAD EPS (TTM)×687.00x DDOG P/E=$1,580.10
Market $28.04Implied $1,580.10
DDOG · current priceP/E 687.00x
$212.97Latest market snapshot
Implied fair value · at ACAD's multiple
$3.7898.2% below market
0.31 DDOG EPS (TTM)×12.19x ACAD P/E=$3.78
Market $212.97Implied $3.78